Journal
VIROLOGY
Volume 508, Issue -, Pages 199-212Publisher
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.virol.2017.05.016
Keywords
HIV-1; Virus capture; Virus entry; alpha 4 beta 7 integrin; V1V2 domain; Envelope glycoprotein; HIV vaccine
Categories
Funding
- NIAID, NIH [AI102725]
- HJF [W81XWH-11-2-0174]
- [F32AI115912]
Ask authors/readers for more resources
The alpha 4137 integrin present on host cells recognizes the V1V2 domain of the HIV-1 envelope protein. This interaction might be involved in virus transmission. Administration of alpha 4 beta 7-specific antibodies inhibit acquisition of SIV in a macaque challenge model. But the molecular details of V1V2: alpha 4 beta 7 interaction are unknown and its importance in HIV-1 infection remains controversial. Our biochemical and mutational analyses show that glycosylation is a key modulator of V1V2 conformation and binding to alpha 4 beta 7. Partially glycosylated, but not full; glycosylated, envelope proteins are preferred substrates for alpha 4 beta 7 binding. Surprisingly, monomers of the envelope protein bound strongly to alpha 4 beta 7 whereas trimers bound poorly. Our results suggest that a conformationally flexible V1V2 domain allows binding of the HIV-1 virion to the alpha 4 beta 7 integrin, which might impart selectivity for the poorly glycosylated HIV-1 envelope containing monomers to be more efficiently captured by alpha 4 beta 7 integrin present on mucosal cells at the time of HIV-1 transmission.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available